Keyword: Flagship Pioneering
Bob Hugin retires from Celgene, Voyager founder steps down as CEO, Boehringer named new U.S. chief to replace retiring Fonteyne.
Venture capital firm Flagship Pioneering has got a major $618 million in capital, the biggest in its 17-year history, topping its total to $2.3 billion.
The clinical trial recorded one partial or complete response among the 48 evaluable patients, wiping 50% off Syros’ stock.
The series C, which moves Codiak’s total haul up toward $170 million, tees the biotech up to move its lead candidate into clinical trials.
Flagship Pioneering has launched its latest biotech, Torque, as it hopes to power through using a new class of “deep-primed” immune cell therapies in cancer.
The extension puts Visterra back on the multifront path through the clinic it plotted out before its aborted IPO attempt.
KSQ has interrogated 20,000 human genes across 600 cancer- and immune-based models, providing it with a wealth of data to power drug discovery.
VC Lightstone has $250 million in the bank for life science research.
Venture capital group Flagship Pioneering filed a $500 million offering with the Securities & Exchange Commission to set up a sixth investment fund.